None listed
Conditions
Brief summary
A number of small studies have investigated the therapeutic potential of repetitive transcranial magnetic stimulation (rTMS) for OCD by stimulating an area of the frontal lobe called the DLPFC. On the whole, the results of these studies have not been encouraging. The current project aims to compare the clinical efficacy of rTMS for OCD at two promising novel treatment targets: right sided premotor cortex versus bilateral supplementary motor area. Participation in the trial involves having two MRI brain scans and four weeks of inpatient rTMS treatment in Melbourne, Australia.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
1. Have a DSM-IV diagnosis of an obsessive compulsive disorder. 2. Have treatment resistance as defined by a failure to respond to at least two trials of adequate dose and duration of appropriate medications (serotonin reuptake inhibitor medications or clomipramine). 3. Have had no increase or initiation of new medication therapy in the 6 weeks prior to screening.
Exclusion criteria
1. Have an unstable medical condition, neurological disorder or any history of a seizure disorder or are currently pregnant or lactating. 2. Have a current DSM IV diagnosis of substance abuse or dependence disorder, a diagnosis of a personality disorder or another axis 1 disorder except depression or another anxiety disorder. 3. Any contraindication to TMS or MRI scanning.